Primary data · sourced from public filings·700+ listed companies · India-first·Claude API · Healthy · —msOpen screener
Aletheia
ScreenerDisclosuresReportsMREEarningsNewsInsightsGlossary
✦Zeptoraises$340Mseries-c·Inc42✦Rapidoraises$120Mseries-b·YourStory✦Krutrimraises$50Mseries-a·Entrackr✦Perfiosraises$80Mseries-b·VCCircle✦Zetwerkraises$210Mseries-d·Inc42✦Amagiraises$100Mseries-c·YourStory✦Sarvam AIraises$41Mseries-a·Entrackr✦Leap Financeraises$55Mseries-b·VCCircle✦Zeptoraises$340Mseries-c·Inc42✦Rapidoraises$120Mseries-b·YourStory✦Krutrimraises$50Mseries-a·Entrackr✦Perfiosraises$80Mseries-b·VCCircle✦Zetwerkraises$210Mseries-d·Inc42✦Amagiraises$100Mseries-c·YourStory✦Sarvam AIraises$41Mseries-a·Entrackr✦Leap Financeraises$55Mseries-b·VCCircle

Aletheia · Disclosure Card

Dr. Reddy's Labs

DRREDDY · Pharma

MARKET CAP

₹1.1L Cr

PE

16.8x

PB

2.8x

ROE

18.4%

REV GROWTH

14.8%

DISCLOSURE HEALTH SCORE

84/100
HIGH QUALITY

Strong across all disclosure dimensions. Holds up to scrutiny.

01ADEQUATE
22.4%ADEQUATE14/20

ROCE of 22.4% clears the threshold but has limited spread over WACC. Monitor trajectory.

02STRONG
1.22STRONG20/20

OCF/PAT ratio of 1.22 — cash flow comfortably exceeds reported profit. Earnings are real.

03CLEAN
0% pledgedCLEAN20/20

No promoter pledge. Promoter holding is unencumbered — full alignment with minority shareholders.

04CONSERVATIVE
D/E 0.1xCONSERVATIVE16/20

D/E of 0.1x. Conservative leverage. Cash flows easily service debt.

05ADEQUATE
3.4% FCF yieldADEQUATE14/20

FCF yield of 3.4%. Positive cash generation. Adequate for dividend or selective buyback.

← BACK TO SCREENERSECTOR PE →GET FULL AUDIT →

Data is representative and for educational purposes only. Not investment advice. Verify all data on Screener.in, BSE, or NSE before any investment decision.

AletheiaAI — The truth layer for India's public markets. 700+ companies, scored.